Serving hundreds of leading biopharmaceutical companies globally:

Generated: October 16, 2018

DrugPatentWatch Database Preview

Glenmark Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for GLENMARK PHARMS, and what generic and branded alternatives to GLENMARK PHARMS drugs are available?

GLENMARK PHARMS has sixty-eight approved drugs.

There are eight tentative approvals on GLENMARK PHARMS drugs.

Summary for Glenmark Pharms

US Patents:	0
Tradenames:	54
Ingredients:	51
NDAs:	68

Drugs and US Patents for Glenmark Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glenmark Pharms Ltd	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING;ORAL	201914-001	Jul 1, 2013	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	DESMOPRESSIN ACETATE	desmopressin acetate	TABLET;ORAL	201831-001	May 28, 2015	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	OLMESARTAN MEDOXOMIL	olmesartan medoxomil	TABLET;ORAL	203281-002	May 25, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	RIZATRIPTAN BENZOATE	rizatriptan benzoate	TABLET, ORALLY DISINTEGRATING;ORAL	201914-002	Jul 1, 2013	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	DROSPIRENONE AND ETHINYL ESTRADIOL	drospirenone; ethinyl estradiol	TABLET;ORAL	204296-001	Aug 17, 2015	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	INDOMETHACIN	indomethacin	CAPSULE, EXTENDED RELEASE;ORAL	203501-001	Jun 22, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Glenmark Pharms Ltd	FENOFIBRATE (MICRONIZED)	fenofibrate	CAPSULE;ORAL	205566-001	Apr 7, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office

Healthtrust

Citi

AstraZeneca

UBS

Argus Health

Moodys

Teva

Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.